Curacle Co Ltd
365270
Company Profile
Business description
Curacle Co Ltd is engaged in developing innovative new drugs with creative technology for incurable diseases caused by the aging process and damage to blood vessels.
Contact
54, Changeop-ro, Sujeong-gu
Ga dong, No. 608~611, Business growth support center
Sujeong-gu, Gyeonggi-do
Seongnam-si608~611
KORT: +82 317068300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
34
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,853.70 | 60.20 | -0.76% |
| CAC 40 | 7,095.26 | 30.76 | -0.43% |
| DAX 40 | 20,291.91 | 270.82 | -1.32% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,950.78 | 37.53 | 0.47% |
| HKSE | 20,914.69 | 232.91 | 1.13% |
| NASDAQ | 16,387.31 | 737.66 | -4.31% |
| Nikkei 225 | 33,585.58 | 1,023.42 | -2.96% |
| NZX 50 Index | 12,019.13 | 182.30 | -1.49% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,646.50 | 63.10 | -0.82% |
| SSE Composite Index | 3,238.23 | 14.59 | 0.45% |